OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer
Jianxia Li, Cheng Wu, Huabin Hu, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1152-1169.e7
Closed Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics
Suoqin Jin, Maksim V. Plikus, Qing Nie
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 93

CellChat for systematic analysis of cell–cell communication from single-cell transcriptomics
Suoqin Jin, Maksim V. Plikus, Qing Nie
Nature Protocols (2024)
Closed Access | Times Cited: 81

Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39

Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 23

New insights into the role of macrophages in cancer immunotherapy
Zhou Li, Tiantian Zhao, Ruzhe Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 19

Exploiting temporal aspects of cancer immunotherapy
Rachael M. Zemek, Valsamo Anagnostou, Inês Pires da Silva, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 480-497
Closed Access | Times Cited: 16

A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
Amelia Acha‐Sagredo, Pietro Andrei, Kalum Clayton, et al.
Cancer Cell (2025)
Open Access | Times Cited: 3

New insight in immunotherapy and combine therapy in colorectal cancer
Kai Ji, Hang Jia, Zixuan Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 2

Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer
Daniel Borràs, Sara Verbandt, Markus Außerhofer, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 38

Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment
Karl Knipper, Su Ir Lyu, Alexander Quaas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13482-13482
Open Access | Times Cited: 23

CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
Qi Lv, Yishu Zhang, Wenxue Gao, et al.
Pharmacological Research (2024) Vol. 202, pp. 107126-107126
Open Access | Times Cited: 14

Photothermal Fe3O4 nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy
Yue Li, Jia Chen, Qi Xia, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13

The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases
Yuhua Zhou, Yuwei Zhang, Shengkai Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117031-117031
Open Access | Times Cited: 11

Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis
Jiali Dong, Bin Wang, Yunong Xiao, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113846-113846
Open Access | Times Cited: 9

Prognostic models of immune-related cell death and stress unveil mechanisms driving macrophage phenotypic evolution in colorectal cancer
Hao Liu, Chuhan Zhang, Sanfei Peng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells
Haoxian Ke, Peisi Li, Z. Y. Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 1

Disruption of GPSM1/CSF1 signaling reprograms tumor-associated macrophages to overcome anti-PD-1 resistance in colorectal cancer
Yang Chen, Huiqing Jia, Xiangyan Zhang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010826-e010826
Open Access | Times Cited: 1

Emerging clinical applications of single-cell RNA sequencing in oncology
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1

Tumor-agnostic drug development in dMMR/MSI-H solid tumors
Deepak Bhamidipati, Vivek Subbiah
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 828-839
Open Access | Times Cited: 20

Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study
Yalei Zhang, Ling Qian, Kun Chen, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 2000-2020
Open Access | Times Cited: 8

Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future
Han Zhang, Xinghua Lu, Binfeng Lu, et al.
Future Oncology (2024) Vol. 20, Iss. 17, pp. 1207-1220
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top